Nectar Lifesciences Board Meeting on Aug 14, 2026 for Unaudited Financials

Nectar Lifesciences Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item for this meeting is the consideration and approval of the Unaudited Financial Results for the quarter ended June 30, 2026. The meeting is being held in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically concerning regulations 29, 30, and 33. This announcement serves as formal notification to the BSE regarding the scheduled board meeting and its financial reporting purpose.